This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Peter Korytko, Ph.D.
President at Preclinical GPS
Speaker

Profile

Peter Korytko is a toxicologist with 24 years of experience in nonclinical drug development (Pfizer, Amgen, and as independent consultant). Peter was the lead toxicologist and author of nonclinical regulatory documents for 46 Phase 1 starts, 23 Phase 2 starts, and 2 NDAs. Peter Korytko is Past President of the Round Table of Toxicology Consultants, Past President of a regional chapter of Society of Toxicology, Advisory Board Member for Boulder Peptide Society, and Chair of Seattle PBSS.

Agenda Sessions

  • Nonclinical Aspects of an IND

    1:40pm